Abstract
ObjectiveLittle is known concerning the stability of the lower airway microbiome. We have compared the microbiota identified by repeated bronchoscopy in healthy subjects and patients with ostructive lung diseaseases (OLD).Methods21 healthy controls and 41 patients with OLD completed two bronchoscopies. In addition to negative controls (NCS) and oral wash (OW) samples, we gathered protected bronchoalveolar lavage in two fractions (PBAL1 and PBAL2) and protected specimen brushes (PSB). After DNA extraction, we amplified the V3V4 region of the 16S rRNA gene, and performed paired-end sequencing (Illumina MiSeq). Initial bioinformatic processing was carried out in the QIIME-2 pipeline, identifying amplicon sequence variants (ASVs) with the DADA2 algorithm. Potentially contaminating ASVs were identified and removed using the decontam package in R and the sequenced NCS.ResultsA final table of 551 ASVs consisted of 19 × 106 sequences. Alpha diversity was lower in the second exam for OW samples, and borderline lower for PBAL1, with larger differences in subjects not having received intercurrent antibiotics. Permutational tests of beta diversity indicated that within-individual changes were significantly lower than between-individual changes. A non-parametric trend test showed that differences in composition between the two exams (beta diversity) were largest in the PSBs, and that these differences followed a pattern of PSB > PBAL2 > PBAL1 > OW. Time between procedures was not associated with increased diversity.ConclusionThe airways microbiota varied between examinations. However, there is compositional microbiota stability within a person, beyond that of chance, supporting the notion of a transient airways microbiota with a possibly more stable individual core microbiome.
Highlights
Microbiota studies of the lungs are subject to specific challenges
We started out with 895 samples, that were reduced to altoghether 727 samples with 19 million sequences distributed over 551 amplicon sequence variants (ASVs)
We first compared the taxonomical composition of the PBAL1 at the phylum level for individual participants at exam 1 and exam 2 (Fig. 2)
Summary
Microbiota studies of the lungs are subject to specific challenges. The biomass in the lower airways is low [1, 2] and prone to the influence of contaminantsNielsen et al BMC Pulm Med (2021) 21:342 studies pointing to both a more and less diverse microbiota with the disease. Little is truly known about the stability of the airway microbiota over time, but at least three studies have published results on repeat bronchoscopies [4,5,6]. They were all intervention studies, but one of them included a control group that was subject to repeated bronchoscopy [4]. In a control group of 10 individuals they reported no significant changes, but the study did not aim to investigate the degree of stability of the microbiome in individuals, and did not visualize the changes in the microbial composition of the airway samples of the individual participants in the control group
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have